Huiyu Pharmaceutical (688553.SH) received a drug registration certificate for dihydroxypropylline injection

Zhitongcaijing · 07/01 09:57

Zhitong Finance App News, Huiyu Pharmaceutical (688553.SH) announced that Sichuan Huiyu Haiyue Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The name of the drug is dihydroxypropylline injection, and dihydroxypropylline is an anti-asthmatic drug. Basically similar to aminophylline, its bronchodilator effect is about 1/10 that of aminophylline. This product has a direct relaxing effect on smooth respiratory muscles, enhances diaphragm contractility, improves respiratory function; it also stimulates the myocardium and increases cardiac blood discharge. This product is suitable for relieving wheezing symptoms such as bronchial asthma, asthmatic bronchitis, and obstructive emphysema. It can also be used for wheezing due to cardiogenic pulmonary edema.